Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-14 · accession 0001104659-26-017082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-18 | 2026-02-14 | RYTM | Mazabraud Yann | EVP, Head of International | M - OptEx | — | +10.0K | 53.2K | +23% | — |
| D | 2026-02-18 | 2026-02-14 | RYTM | Mazabraud Yann | EVP, Head of International | M - OptEx | $0.00 | -10.0K | 30.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-14 | M | A | 10,000 | — | 53,155 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Derivative | Restricted Stock Units | 2026-02-14 | M | D | 10,000 | $0.00 | 30,000 | D | — · — to — | 10,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F2) The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. |